MyndVR and HTC VIVE announced the launch of DigitalTherapyNOW.org, a purpose-driven coalition to support the successful passing of the Access to Prescriptive Digital Therapeutics Act of 2022.
MyndVR, the award-winning provider of immersive, therapeutic VR experiences designed for the aging population, and HTC VIVE, a global leader in VR technology, announced the launch of DigitalTherapyNOW.org, a purpose-driven coalition of academic and industry partners designed to educate lawmakers to support the successful passing of the Access to Prescriptive Digital Therapeutics Act of 2022. This growing coalition is also supported by the XR Association (XRA), International VR Healthcare Association (IVRHA), and National Association of State Veteran Homes (NASVH).
The bipartisan legislation, proposed by Reps. Mike Thompson (CA-05) and David McKinley (WV-01) and Sens. Jeanne Shaheen (D-NH) and Shelly Moore Capito (R-WV), would expand Medicare coverage to include prescription digital therapeutics (PDTs), which are software-based
treatments designed to prevent, treat and manage diseases. The Access to Prescription Digital Therapeutics Act aims to officially define prescription digital therapeutics (PDTx) at the federal level and establish new payor benefit categories for PDTx. If passed, the bill could improve healthcare access for more than 148 million Americans.
“We are excited to see members of Congress coming together for such an important piece of legislation,” said Chris Brickler, founder and CEO of MyndVR. “Virtual Reality isn’t just for gamers. We believe VR-based, digital therapeutics have a very bright future in cognitive, physical and emotional health. Our seniors have earned this technology and we are asking lawmakers across the country to join us and pass S.3791.”
“Over the last 15 years, we’ve been exploring ways to use immersive technology to improve quality of life for those facing a wide array of psychiatric and neurological conditions,” said Dr. Adam Gazzaley. “I am excited about the next frontier of VR-based, clinical research and how these digital prescriptions of the future may benefit aging adults and their caregivers.”
“XRA’s member companies are working to leverage cutting edge digital software to improve patient outcomes,” said Liz Hyman, CEO of the XR Association. “We’re proud to advocate for policies that anticipate and mitigate challenges in the responsible development and deployment of XR technology.”
Learn more at www.DigitalTherapyNow.org